N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity

Original document(18 pages) 中文版

The invention relates to a method for designing and synthesizing N2-fragrant formyl-4-amido /amido-pteridines derivation with Nitric Oxide Synthase, which has the structure of (I), wherein R1 and R2 at least has one fragrant formyl. The pteridines compound can adjust the activity of NOS and can prepare for the drug.

Application Number 申请号	200610037672	Application Date 申请日	2006.01.10
Title 名称	N2-arylformyl-4-ammonia/amidopteridine analog compound capable of regulating nitrous oxide synthase acitivity
Publication Number 公开号	1800182	Publication Date 公开日	2006.07.12
Approval Pub. Date		Granted Pub. Date
International Classification 分类号	C07D475/08,A61K31/519,A61P29/00,A61P11/06,A61P9/12,A61P9/10
Applicant(s) Name 申请人	China Pharmaceutical University
Address 地址	210009
Inventor(s) Name 发明人	Yao Qizheng, Tang Feng, Li Xiaoliang
Attorney & Agent 代理人

One-step synthesis process for pemetrexed disodium key intermediate
Synthesis of temozolomide and analogs
Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
Adenosine a2a receptor antagonists
Taspine alkaline preparation method and uses in preparing medicine for treating tumour
Method for separating and preparing triptolide diol from tripterygium wilfordii
Method for separating vindoline , catharanthine, vinblastine and vincristine from Vinca rosea
Volatile metal beta-ketoiminate complexes
Cyclic carbonate-modified organosilicon compound, non-aqueous electrolytic solution, secondary battery and capacitor
Novel chemical bonding chiral immobile phase and its preparation method and uses

Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.